Inflacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs and cats.
Inflacam contains the active substance meloxicam and is a generic medicine. This means that Inflacam contains the same active substance and works in the same way as a ‘reference medicine’ already authorised in the European Union (EU) called Metacam.
In cattle, Inflacam is used together with appropriate antibiotic therapy, to reduce clinical signs of acute respiratory infection (infection of the lungs and airways). It can be used with oral re-hydration therapy (medicines given by mouth to restore water levels in the body) to reduce diarrhoea in calves of over one week of age and young, non-lactating cattle. It can also be used as supportive therapy in the treatment of acute mastitis (inflammation of the udder), in combination with antibiotics.
In pigs, Inflacam is used to reduce lameness and inflammation in non-infectious locomotor disorders (diseases that affect the ability to move), for the relief of post-operative pain after minor soft tissue surgery such as castration, and for supportive therapy together with appropriate antibiotic therapy in the treatment of diseases that occur after farrowing (giving birth) such as puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome). Septicaemia and toxaemia are conditions where bacteria circulate in the blood and produce harmful substances (toxins).
In horses, Inflacam is used to reduce pain associated with colic (abdominal pain) and to lessen inflammation and relieve pain in acute and chronic musculo-skeletal disorders (disorders affecting the muscles and bones).
In dogs, Inflacam is used to reduce post-operative pain and inflammation following orthopaedic (e.g. fracture operation) and soft tissue surgery. Moreover, it is used to lessen inflammation and pain in acute and chronic musculo-skeletal disorders.
In cats, Inflacam is used to reduce post-operative pain and inflammation after ovariohysterectomy (spaying operation), orthopaedic and minor soft tissue surgery. Moreover it is used to lessen inflammation and pain in acute and chronic musculo-skeletal disorders in cats.
Inflacam : EPAR - Medicine overview (PDF/82.16 KB)
First published: 16/12/2011
Last updated: 12/12/2018
|Agency product number||
|International non-proprietary name (INN) or common name||
|Anatomical therapeutic chemical veterinary (ATCvet) codes||
This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.
Chanelle Pharmaceuticals Manufacturing Ltd
|Date of issue of marketing authorisation valid throughout the European Union||
18/03/2021 Inflacam - EMEA/V/C/002497 - IB/0024
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Anti-inflammatory and anti-rheumatic products, non-steroids
Dogs: alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.
To reduce post-operative pain and inflammation following orthopaedic and soft tissue surgery.
Cats: to reduce post-operative pain after ovariohysterectomy and minor soft tissue surgery.
Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.
Alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders in cats.
Cattle: for use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs.
For use in diarrhoea in combination with oral re‑hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.
For the relief of post-operative pain following dehorning in calves.
Pigs: for use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.
For the relief of post operative pain associated with minor soft tissue such as castration.
Horses: alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.
For the relief of pain associated with equine colic.